help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamaki, H.
Right arrow Articles by Miyai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamaki, H.
Right arrow Articles by Miyai, K.

Journal of Clinical Endocrinology & Metabolism, Vol 71, 1382-1386, Copyright © 1990 by Endocrine Society


ARTICLES

Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan

H Tamaki, N Amino, M Kimura, Y Hidaka, K Takeoka and K Miyai
Department of Laboratory Medicine, Osaka University Medical School, Japan.

The prevalence of TSH receptor antibody (TRAb), measured by RRA assay (TSH-binding inhibitor immunoglobulin, TBII) and biological stimulation- blocking assay (thyroid-stimulation blocking antibody, TSBAb), was examined in 134 consecutive patients with primary hypothyroidism due to autoimmune thyroiditis [83 patients with goitrous Hashimoto's disease (group A) and 51 with primary atrophic hypothyroidism (group B)]. In group A, TBII was detected in 6 patients (7%), TSBAb in 7 (8%), and both in 4 (5%). Similarly, in group B, TBII was detected in 7 patients (14%), TSBAb in 7 (14%), and both in 5 (10%). TBII with TSBAb activity was low or moderate in group A, but strongly positive in group B. No relationship was apparent in either group between TBII or TSBAb activity and any clinical or laboratory parameter examined. Moreover, no clinical or laboratory findings distinguished patients with TRAb from those without. The low prevalence of TRAb in primary hypothyroidism suggests that intrathyroidal cell-mediated destructive mechanisms may be more important in the pathogenesis of hypothyroidism in autoimmune thyroiditis.


This article has been cited by other articles:


Home page
NEJMHome page
E. N. Pearce, A. P. Farwell, and L. E. Braverman
Thyroiditis
N. Engl. J. Med., June 26, 2003; 348(26): 2646 - 2655.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Akamizu, L. D. Kohn, H. Hiratani, M. Saijo, K. Tahara, and K. Nakao
Hashimoto's Thyroiditis with Heterogeneous Antithyrotropin Receptor Antibodies: Unique Epitopes May Contribute to the Regulation of Thyroid Function by the Antibodies
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2116 - 2121.
[Abstract] [Full Text]


Home page
NEJMHome page
C. M. Dayan and G. H. Daniels
Chronic Autoimmune Thyroiditis
N. Engl. J. Med., July 11, 1996; 335(2): 99 - 107.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society